Toggle light / dark theme

The new approach has the potential to open a powerful avenue in cellular manipulation. Whereas DNA editing makes permanent changes to the genome of a cell, the CRISPR-based RNA-targeting approach may allow researchers to make temporary changes that can be adjusted up or down, and with greater specificity and functionality than existing methods for RNA interference.

In a study published today in Science, Feng Zhang and colleagues at the Broad Institute and the McGovern Institute for Brain Research at MIT, along with co-authors Eugene Koonin and his colleagues at the NIH, and Konstantin Severinov of Rutgers University-New Brunswick and Skoltech, report the identification and functional characterization of C2c2, an RNA-guided enzyme capable of targeting and degrading RNA.

The findings reveal that C2c2—the first naturally-occurring CRISPR system that targets only RNA to have been identified, discovered by this collaborative group in October 2015—helps protect bacteria against viral infection. They demonstrate that C2c2 can be programmed to cleave particular RNA sequences in bacterial cells, which would make it an important addition to the molecular biology toolbox.

Read more

A group of scientists on Thursday proposed an ambitious project to create a synthetic human genome, or genetic blueprint, in an endeavour that is bound to raise concerns over the extent to which human life can or should be engineered.

The project, which arose from a meeting of scientists last month at Harvard University, aims to build such a synthetic genome and test it in cells in the laboratory within 10 years. The project was unveiled in the journal Science by the experts involved.

Read more

A 3D hydrogel biochip, a new way of detecting colorectal cancer in the early stages, has been discovered by the scientists at the Moscow Institute of Physics and Technology. The announcement was made in time for the upcoming conference of the annual American Society of Clinical Oncology.

Like Us on Facebook

The 3D hydrogel biochip will be using antibodies to determine the CRC specific glycans that emerge in the earliest stages of cancer, with the hope of improving today’s survival rates. These biochips are 3D cells consisting of a special gel that has molecular probes. Based on reports, the physical feature of the gel is an optimal form for running tests. The Russian scientists were able to develop a method that can calculate the concentration of antibodies-to-glycans in the patient’s blood. This means that combining the biochips into a patient’s blood sample will give the mot precise results.

Read more

3D printing is proving to be a must in combat training for troops.


CAMP LEJEUNE, N.C.—Marines are learning to use 3D printers.

Marines from 2nd Maintenance Battalion, 2nd Marine Logistics Group are being trained to use the 3D printers that could come in handy on deployments.

“Basically anything that’s a 3D object or 3D image we can take, slice up and print on these printers,” said Francis Marion University Assistant Professor Justin Yates.

A feel good story on 3D printers.


This lil’ kitty named Sonic is now bionic.

The black-and-white cat, who was surrendered to Denver Animal Shelter over three months ago, had been born with a leg deformity called radial agenesis, according to Meghan Hughes, communications director for Denver Environmental Health.

Because of the deformity, Sonic was forced to drag his leg on the ground to move, she told ABC News today.

German researchers on Wednesday presented a Trojan horse method of attacking cancer, sneaking virus impersonators into the human body to unleash an anti-tumour immune offensive.

Tested in only three people so far, the treatment claims to be the latest advance in immunotherapy, which aims to rouse the body’s own immune army against disease.

Made in the lab, this Trojan horse is composed of nanoparticles containing RNA—a form of genetic coding—enclosed by a fatty acid membrane.

Read more

Scientists have successfully created mice with significantly longer telomeres than normal, resulting in a drop in molecular ageing, without using genetic manipulation.

Telomeres, which are found at the end of all animals’ chromosomes, are thought to be vital to ending ageing, as their shortening as we age is a key factor in cellular ageing and the onset of age-related disease. However, when they are lengthened beyond normal levels in mice, they have the precise opposite effect, protecting against ageing and related diseases, and increasing lifespan.

The mice, which are chimeras carrying both regular and “hyper-long” telomeres, were created using a technique based on epigenic changes, where embryonic stem cells are expanded in vitro, prompting changes to telomeres.

Read more

The cells with hyper-long telomeres in these mice appear to be perfectly functional. When the tissues were analysed at various moments (0, 1, 6 and 12 months of life), these cells maintained the additional length scale (they shortened over time but at a normal rhythm), accumulated less DNA damage and had a greater capacity to repair any damage. In addition, the animals presented a lower tumour incidence than normal mice.

These results show that pluripotent stem cells that carry hyper-long telomeres can give rise to organisms with telomeres that remain young at the molecular level for longer. According to the authors, this “proof of concept means that it is possible to generate adult tissue with longer telomeres in the absence of genetic modifications”.


The Telomeres and Telomerase Group at the Spanish National Cancer Research Centre (CNIO), in collaboration with the Centre’s Transgenic Mice Core Unit, has succeeded in creating mice in the laboratory with hyper-long telomeres and with reduced molecular ageing, avoiding the use of what to date has been the standard method: genetic manipulation. This new technique based on epigenetic changes that is described today in the pages of Nature Communications, avoids the manipulation of genes in order to delay molecular ageing. The study also underlines the importance of this new strategy in generating embryonic stem cells and iPS cells with long telomeres for use in regenerative medicine.

Telomeres (the protective structures located at the ends of chromosomes) are essential to the stability of our genetic material and to maintain the “youthful state” of our and of our bodies. However, get shorter as we age. Once they reach a critical length, cells enter a state of senescence or die. This is one of the molecular causes of cellular ageing and of the emergence of ageing-related diseases.